"Biopure oxyglobin hemopure" Essays and Research Papers

Sort By:
Satisfactory Essays
Good Essays
Better Essays
Powerful Essays
Best Essays
Page 1 of 6 - About 52 Essays
  • Good Essays

    by Oxyglobin without jeopardizing the potential of Hemopure is a tough problem for Biopure’s executive. According to the financial analysis‚ it is suggested that Biopure begin to sell Oxyglobin at $150 per unit to emergency care practice at the Veterinary Blood Market and have its own distribution network. This will make a profit of $5 million at first year and $17 million thereafter. The steadfast income will consolidate Biopure’s financial structure and enhance the competiveness of Hemopure. The

    Premium Blood Marketing Economics

    • 616 Words
    • 3 Pages
    Good Essays
  • Satisfactory Essays

    CEO of Biopure Corporation FROM: Hoang‚ Ann and Mishra‚ Ravi RE: Whether and When to Launch Oxyglobin Biopure needs to determine the best course of action to launch two new products‚ Oxyglobin a blood substitute for the veterinary market and Hemopure a blood substitute for the human market. Oxyglobin has been approved for commercial use and is ready for launch while Hemopure is expected to be FDA approved within two years. Biopure needs to decide whether and when to launch Oxyglobin. If decided

    Premium Blood Blood transfusion Marketing

    • 1016 Words
    • 5 Pages
    Satisfactory Essays
  • Better Essays

    Q1. Should Biopure launch Oxyglobin? Why? Support your arguments with quantitative analysis (ie. calc. of market potential). We believe that Biopure should launch Oxyglobin now. First of all‚ the potential market demand is huge. While current annual demand is 354‚750 units (95% primary care practices x 17 units canine blood/primary care practice + 5% specialty care practices x 150 units canine blood/specialty care practice)i accounting for only 2.5% of the cases‚ potential market demand including

    Premium Blood Marketing Blood transfusion

    • 1310 Words
    • 6 Pages
    Better Essays
  • Good Essays

    Oxyglobin

    • 1052 Words
    • 5 Pages

    1. What are the reasons for and against launching Oxyglobin? Reasons FOR launching Oxyglobin | Reason AGAINST launching Oxyglobin | Setting the preferences for the customer‚ framing their perceptions of later entrants‚ becoming the standard | Risk of justifying price premium in human market vs. vet | Conduct pre-emptive positioning to raise the barriers to entry in to this market | Human market much larger and more lucrative than vet market | Develop relationships with customers and build

    Premium Marketing Strategic management Management

    • 1052 Words
    • 5 Pages
    Good Essays
  • Satisfactory Essays

    Biopure

    • 1060 Words
    • 5 Pages

    Brief Overview: Biopure has two new products namely Oxyglobin and Hemopure. Oxyglobin is a first of its kind‚ new blood substitute for the veterinary market and has passed all the tests and is ready for consumer use. Hemopure is another such blood substitute for the human market and it will take a minimum of two years to launch the product from now. There is a concern about creating an unrealistic price expectation for Hemopure by marketing Oxyglobin before Hemopure. Whereas another point of view

    Free Blood Blood transfusion

    • 1060 Words
    • 5 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Biopure

    • 386 Words
    • 2 Pages

    Biopure Overview: * Biopure Corporation is a privately owned biopharmaceutical firm specializing in the ultrapurification of proteins for human and veterinary use. * It is one of the three legitimate contenders in the emerging field of “blood substitutes”. * Their products Oxyglobin and Hemopure are blood substitutes for the animal and the human market respectively. * Oxyglobin has just received final FDA approval for commercial release and is ready for launch. Hemopure would soon

    Premium Blood Blood transfusion

    • 386 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    Biopure

    • 3679 Words
    • 15 Pages

    Executive Summary Marketing Plan for launching Oxyglobin Push and Pull strategy will be implemented to enhance the marketing plan of launching Oxyglobin. One of the most important aspect in medical is communication‚ we will have sales representation frequently visit practices and doctor in order to align the understanding and needs between Oxyglobin and Doctors. This is to ensure their understanding of the product benefits‚ why the product is selling at premium and why people should choose this

    Free Blood

    • 3679 Words
    • 15 Pages
    Powerful Essays
  • Good Essays

    Biopure Case

    • 7016 Words
    • 29 Pages

    marketing plan of the recommended one. The study shows that Biopure should immediately launch Oxyglobin rather than wait for Hemopure’s FDA Approval then launch both products simultaneously. The proposed price for Oxyglobin is $300 per unit with promotion campaign from time to time. With this set price of immediate launch‚ Biopure will reach breakeven point for Oxyglobin in year 2000 with the amount of 2.13 million USD. Targeting market for Oxyglobin is emergency care practices as a higher price of blood

    Free Blood Blood transfusion

    • 7016 Words
    • 29 Pages
    Good Essays
  • Good Essays

    Biopure Case

    • 1372 Words
    • 6 Pages

    Biopure Corporation: Case Write-Up Problem Definition In February 1998 Biopure Corporation faced a difficult decision regarding the launch of its newly developed “blood substitute” products. Biopure had developed “Hemopure”‚ a blood substitute for humans‚ and an ancillary product “Oxyglobin” for the veterinary market1. Hemopure was still in the process of gaining Federal Drug Administration (FDA) approval ‚ while Oxyglobin had already been approved and was ready to be launched1. FDA approval was

    Premium Blood Blood transfusion Pricing

    • 1372 Words
    • 6 Pages
    Good Essays
  • Better Essays

    Biopure Case

    • 1638 Words
    • 7 Pages

    BioPure Corporation‚ which was founded in 1984 by entrepreneurs Carl Rausch and David Judelson‚ is a privately owned biopharmaceutical firm specializing in the ultra purification of proteins for human and veterinary use. In 1998 Biopure pioneered the development of oxygen therapeutics using "Hemoglobin"‚ a new class of pharmaceuticals that are intravenously administered to deliver oxygen to the body’s tissues. Biopure’s two products‚ Hemopure for human use‚ and Oxyglobin for animal veterinary use

    Free Blood Blood transfusion Blood bank

    • 1638 Words
    • 7 Pages
    Better Essays
Previous
Page 1 2 3 4 5 6